Gail Boudreaux bought $1.0M of ELV
President and CEO at Elevance Health, Inc.. 2,725 shares at an average of $367.79, traded Jul 17, 2026, filed Jul 17, 2026.
Score components
- +25RoleCEO
- +25Trade size$1.0M at market
- 0Relative to holdingsHoldings up 1.6%
- 0Price contextNear the top of the 52-week range
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (1 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001287920-26-000006, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 17, 2026 | POpen-market purchase Common Stock | +680 | $366.41 | $249k | 169,931 | Jul 17, 2026 |
| Jul 17, 2026 | POpen-market purchase Common Stock | +2,045 | $368.25 | $753k | 171,976 | Jul 17, 2026 |
Related signals
Other insiders at Elevance Health, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 41Moderate | Elevance Health, Inc. | Ramiro G Peru director | $366k 1,000 shares | +10% | |
| 34Weak | Elevance Health, Inc. | Ronald W Penczek CAO & Controller | $149k 369 shares | -9% | |
| 30Weak | Elevance Health, Inc. | Robert L Dixon JR director | $61k 151 shares | -1% | |
| 30Weak | ELVsell Elevance Health, Inc. | Ronald W Penczek CAO & Controller | $617k 1,531 shares | -27% | |
| 28Weak | Elevance Health, Inc. | Amy W Schulman director | $7,475 26 shares | -11% | |
| 52Moderate | Elevance Health, Inc. | Charles Morgan Kendrick JR EVP & President, Commercial | $911k 3,196 shares | -21% | |
| 66Notable | ELVbuy Elevance Health, Inc. | Steven H Collis director | $870k 3,000 shares | +469% | |
| 48Moderate | ELVbuy Elevance Health, Inc. | Susan D. DeVore director | $375k 1,200 shares | +52% | |
| 71Notable | ELVbuy Elevance Health, Inc. | Gail Boudreaux President and CEO | $2.4M 8,500 shares | +6% | |
| 52Moderate | ELVsell Elevance Health, Inc. | Mark Kaye EVP & CFO | $1.9M 4,588 shares | -19% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.